Diagnoplex
Lausanne
About Diagnoplex
Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert Rüf Stiftung. The company has performed a 140 patient prospective pilot study demonstrating technical and clinical feasibility of its colorectal cancer screening test COLOX as well as its high sensitivity and specificity.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $9.9M
- Last round: Series Unknown (Jun 2013)
- Website: diagnoplex.com
- Phone: +41 21 989 20 00
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/diagnoplex-2911257 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.